
NEW YORK (Reuters Health), Aug 26 - Men and people of South Asian descent are more likely to have unfavorable perceptions of colon cancer screening, research from the U.K. shows.
The findings point the way toward strategies to get more people screened, Dr. Taina Taskila of the University of Birmingham, a researcher on the study, told Reuters Health.
For any type of cancer, she noted, it can be difficult to encourage people to get screened and increase awareness of potential symptoms. "It's one of the most feared of all illnesses and people ... don't want to know about it if they don't have to," she said.
Survival from colorectal cancer is much more likely if the disease is detected early, but most cases are found relatively late, Taskila and her colleagues note in the British Journal of Cancer.
The U.K. launched a national program in 2006 to screen all men and women 60 to 69 years old with a fecal occult blood test (FOBT), in which the stool is tested for blood. But studies looking at "uptake" of screening have found fewer than 60% of eligible people are getting tested.
Attitudes toward colorectal cancer screening are a key determinant in whether a person actually gets the test, the researchers add. To better understand why people might be reluctant to undergo screening, they surveyed 11,355 people about their attitudes toward both FOBT and colonoscopy, as well as whether they had symptoms that could indicate colorectal cancer.
While other researches have investigated attitudes toward screening, Taskila noted in an interview, this study is the first to look at whether having symptoms influences these attitudes.
Overall, the researchers found, 14% of the people surveyed had a negative perception of colorectal cancer screening in general, with 13% saying they felt FOBT was "very unacceptable" or "unacceptable," and 55% saying the same of colonoscopy.
Negative attitudes were more common among men, older people, and people of South Asian heritage.
However, people who reported certain potential symptoms of colorectal cancer (tiredness, belly pain, bleeding from the anus, or "pain, soreness, discomfort, itching, or lumps" around the anus) had more favorable attitudes toward screening.
People who had at least three such symptoms were also more likely to have a favorable attitude toward screening than those who reported fewer, while people from a Black Caribbean background had more favorable attitudes than other ethnic groups.
Based on the findings, Taskila and her team say, "culturally relevant screening strategies should be developed" to help make colorectal cancer screening more acceptable to ethnic minorities, and to increase awareness of signs and symptoms of the disease.
By Anne Harding
Source: British Journal of Cancer, July 2009.
Last Updated: 2009-08-26 10:00:37 -0400 (Reuters Health)
Related Reading
Colorectal cancer survival differs by race and ethnicity, November 30, 2007
Copyright © 2009 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.









![Overview of the study design. (A) The fully automated deep learning framework was developed to estimate body composition (BC) (defined as subcutaneous adipose tissue [SAT] in liters; visceral adipose tissue [VAT] in liters; skeletal muscle [SM] in liters; SM fat fraction [SMFF] as a percentage; and intramuscular adipose tissue [IMAT] in deciliters) from MRI. The fully automated framework comprised one model (model 1) to quantify different BC measures (SAT, VAT, SM, SMFF, and IMAT) as three-dimensional (3D) measures from whole-body MRI scans. The second model (model 2) was trained to identify standardized anatomic landmarks along the craniocaudal body axis (z coordinate field), which allowed for subdividing the whole-body measures into different subregions typically examined on clinical routine MRI scans (chest, abdomen, and pelvis). (B) BC was quantified from whole-body MRI in over 66,000 individuals from two large population-based cohort studies, the UK Biobank (UKB) (36,317 individuals) and the German National Cohort (NAKO) (30,291 individuals). Bar graphs show age distribution by sex and cohort. BMI = body mass index. (C) After the performance assessment of the fully automated framework, the change in BC measures, distributions, and profiles across age decades were investigated. Age-, sex-, and height-adjusted body composition reference curves were calculated and made publicly available in a web-based z-score calculator (https://circ-ml.github.io).](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/05/body-comp.XgAjTfPj1W.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)





